Entecavir monohydrate
Product Description
BrightGene Bio-Medical Technology Co.,Ltd.
-
Country/Region:China
-
On CPHI since:2015
-
Employees:1000 - 4999
Company types
Specifications
BrightGene Bio-Medical Technology Co.,Ltd.
-
Country/Region:China
-
On CPHI since:2015
-
Employees:1000 - 4999
Company types
More Products from BrightGene Bio-Medical Technology Co.,Ltd. (49)
-
Product Everolimus（without BHT）
• Status: MF No.: 230MF10023 • Patent Expiration: Off-patent • Usage: Oncology -
Product Midostaurin
• Status: Validated • Patent Expiration: Off-patent • Usage: Oncology -
Product Fondaparinux Sodium
• Status: DMF No. :030767 • Patent Expiration: Off-patent • Usage:Anticoagulant -
Product Anidulafungin
Status:
DMF No.: 032010
ASMF Approved
Patent Expiration: Off-patentUsage: Antifungal -
Product Argatroban Monohydrate
• Status: MF No.: 230MF10028; USDMF to be filed in Q4,2020 • Patent Expiration: Off-patent • Usage:Anticoagulant -
Product Caspofungin Acetate
• Status: ASMF Approved & DMF No.:034091 • Patent Expiration:Off-patent • Usage:Antifungal -
Product Eribulin Mesilate
• Status: Validated • Patent Expiration: US：2023.07.20 ；CN：off-patent • Usage: Oncology -
Product Everolimus(2.0% BHT)
• Status: DMF No.:032020 • Patent Expiration: Off-patent • Usage: Oncology -
Product Fidaxomicin
• Status: DMF No.: 028803 • Patent Expiration: US：2027.03.04; • Usage: Anti-infection -
Product Fondaparinux Sodium
Brightgene Bio-Medical Technology Co.Ltd. Offers a wide range of anti-infective products which includes fondaparinux sodium. It belongs to cardiovascular category. Contact us for more information. -
Product Micafungin Sodium
• Status: • DMF No.:031449 • ASMF Approved • MF No.: 230MF10169 • Patent Expiration: Off-patent • Usage:Antifungal -
Product Posaconazole Amorphous
• Status: DMF No.: 028314 • Patent Expiration: Off-patent • Usage: Antifungal